US Stock MarketDetailed Quotes

VRDN Viridian Therapeutics

Watchlist
  • 21.550
  • -0.320-1.46%
Close Nov 29 13:00 ET
  • 21.550
  • 0.0000.00%
Post 17:01 ET
1.71BMarket Cap-4988P/E (TTM)

Viridian Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
19.44%86K
0.00%72K
-26.53%72K
-82.28%314K
-31.43%72K
-93.97%72K
-71.88%72K
-54.63%98K
-40.20%1.77M
-50.93%105K
Operating revenue
19.44%86K
0.00%72K
-26.53%72K
-82.28%314K
-31.43%72K
-93.97%72K
-71.88%72K
-54.63%98K
-40.20%1.77M
-50.93%105K
Cost of revenue
Gross profit
Operating expense
62.91%83.57M
21.76%72.26M
-22.88%55.97M
87.22%254.76M
45.51%71.55M
65.58%51.3M
99.02%59.35M
178.00%72.57M
64.56%136.08M
67.85%49.17M
Selling and administrative expenses
-31.10%14.41M
-16.60%16.07M
-31.18%15.03M
170.02%95M
234.82%32.99M
135.99%20.91M
137.59%19.26M
161.17%21.83M
36.34%35.18M
42.79%9.85M
-General and administrative expense
-31.10%14.41M
-16.60%16.07M
-31.18%15.03M
170.02%95M
234.82%32.99M
135.99%20.91M
137.59%19.26M
161.17%21.83M
36.34%35.18M
42.79%9.85M
Research and development costs
127.61%69.16M
40.19%56.19M
-19.31%40.94M
58.35%159.77M
-1.93%38.56M
37.37%30.39M
84.61%40.08M
185.92%50.74M
77.36%100.89M
75.57%39.32M
Operating profit
-62.97%-83.48M
-21.78%-72.19M
22.87%-55.9M
-89.46%-254.45M
-45.68%-71.48M
-71.98%-51.22M
-100.50%-59.28M
-179.94%-72.47M
-68.45%-134.3M
-68.72%-49.07M
Net non-operating interest income expense
90.54%6.79M
70.80%7.19M
70.18%7.36M
277.34%16.72M
40.75%4.62M
305.00%3.56M
5,669.86%4.21M
2,105.10%4.32M
1,306.35%4.43M
2,330.37%3.28M
Non-operating interest income
87.20%7.8M
77.96%7.79M
77.00%7.94M
277.60%18.56M
60.45%5.53M
298.85%4.16M
1,828.63%4.38M
2,189.29%4.49M
1,445.91%4.92M
2,399.28%3.45M
Non-operating interest expense
67.33%1M
259.64%597K
255.76%587K
280.04%1.85M
445.24%916K
265.85%600K
7.79%166K
--165K
16,100.00%486K
5,500.00%168K
Other net income (expense)
Income before tax
-60.91%-76.69M
-18.03%-64.99M
28.77%-48.54M
-83.05%-237.73M
-46.03%-66.86M
-64.88%-47.66M
-86.71%-55.06M
-165.25%-68.15M
-63.54%-129.87M
-58.17%-45.79M
Income tax
Net income
-60.91%-76.69M
-18.03%-64.99M
28.77%-48.54M
-83.05%-237.73M
-46.03%-66.86M
-64.88%-47.66M
-86.71%-55.06M
-165.25%-68.15M
-63.54%-129.87M
-58.17%-45.79M
Net income continuous Operations
-60.91%-76.69M
-18.03%-64.99M
28.77%-48.54M
-83.05%-237.73M
-46.03%-66.86M
-64.88%-47.66M
-86.71%-55.06M
-165.25%-68.15M
-63.54%-129.87M
-58.17%-45.79M
Minority interest income
Net income attributable to the parent company
-60.91%-76.69M
-18.03%-64.99M
28.77%-48.54M
-83.05%-237.73M
-46.03%-66.86M
-64.88%-47.66M
-86.71%-55.06M
-165.25%-68.15M
-63.54%-129.87M
-58.17%-45.79M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-60.91%-76.69M
-18.03%-64.99M
28.77%-48.54M
-83.05%-237.73M
-46.03%-66.86M
-64.88%-47.66M
-86.71%-55.06M
-165.25%-68.15M
-63.54%-129.87M
-58.17%-45.79M
Basic earnings per share
-5.50%-1.15
19.69%-1.02
50.93%-0.79
-31.11%-5.31
-19.47%-1.35
-26.74%-1.09
-19.81%-1.27
-64.29%-1.61
39.19%-4.05
6.61%-1.13
Diluted earnings per share
-5.50%-1.15
19.69%-1.02
50.93%-0.79
-31.11%-5.31
-19.47%-1.35
-26.74%-1.09
-19.81%-1.27
-64.29%-1.61
39.19%-4.05
6.61%-1.13
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 19.44%86K0.00%72K-26.53%72K-82.28%314K-31.43%72K-93.97%72K-71.88%72K-54.63%98K-40.20%1.77M-50.93%105K
Operating revenue 19.44%86K0.00%72K-26.53%72K-82.28%314K-31.43%72K-93.97%72K-71.88%72K-54.63%98K-40.20%1.77M-50.93%105K
Cost of revenue
Gross profit
Operating expense 62.91%83.57M21.76%72.26M-22.88%55.97M87.22%254.76M45.51%71.55M65.58%51.3M99.02%59.35M178.00%72.57M64.56%136.08M67.85%49.17M
Selling and administrative expenses -31.10%14.41M-16.60%16.07M-31.18%15.03M170.02%95M234.82%32.99M135.99%20.91M137.59%19.26M161.17%21.83M36.34%35.18M42.79%9.85M
-General and administrative expense -31.10%14.41M-16.60%16.07M-31.18%15.03M170.02%95M234.82%32.99M135.99%20.91M137.59%19.26M161.17%21.83M36.34%35.18M42.79%9.85M
Research and development costs 127.61%69.16M40.19%56.19M-19.31%40.94M58.35%159.77M-1.93%38.56M37.37%30.39M84.61%40.08M185.92%50.74M77.36%100.89M75.57%39.32M
Operating profit -62.97%-83.48M-21.78%-72.19M22.87%-55.9M-89.46%-254.45M-45.68%-71.48M-71.98%-51.22M-100.50%-59.28M-179.94%-72.47M-68.45%-134.3M-68.72%-49.07M
Net non-operating interest income expense 90.54%6.79M70.80%7.19M70.18%7.36M277.34%16.72M40.75%4.62M305.00%3.56M5,669.86%4.21M2,105.10%4.32M1,306.35%4.43M2,330.37%3.28M
Non-operating interest income 87.20%7.8M77.96%7.79M77.00%7.94M277.60%18.56M60.45%5.53M298.85%4.16M1,828.63%4.38M2,189.29%4.49M1,445.91%4.92M2,399.28%3.45M
Non-operating interest expense 67.33%1M259.64%597K255.76%587K280.04%1.85M445.24%916K265.85%600K7.79%166K--165K16,100.00%486K5,500.00%168K
Other net income (expense)
Income before tax -60.91%-76.69M-18.03%-64.99M28.77%-48.54M-83.05%-237.73M-46.03%-66.86M-64.88%-47.66M-86.71%-55.06M-165.25%-68.15M-63.54%-129.87M-58.17%-45.79M
Income tax
Net income -60.91%-76.69M-18.03%-64.99M28.77%-48.54M-83.05%-237.73M-46.03%-66.86M-64.88%-47.66M-86.71%-55.06M-165.25%-68.15M-63.54%-129.87M-58.17%-45.79M
Net income continuous Operations -60.91%-76.69M-18.03%-64.99M28.77%-48.54M-83.05%-237.73M-46.03%-66.86M-64.88%-47.66M-86.71%-55.06M-165.25%-68.15M-63.54%-129.87M-58.17%-45.79M
Minority interest income
Net income attributable to the parent company -60.91%-76.69M-18.03%-64.99M28.77%-48.54M-83.05%-237.73M-46.03%-66.86M-64.88%-47.66M-86.71%-55.06M-165.25%-68.15M-63.54%-129.87M-58.17%-45.79M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -60.91%-76.69M-18.03%-64.99M28.77%-48.54M-83.05%-237.73M-46.03%-66.86M-64.88%-47.66M-86.71%-55.06M-165.25%-68.15M-63.54%-129.87M-58.17%-45.79M
Basic earnings per share -5.50%-1.1519.69%-1.0250.93%-0.79-31.11%-5.31-19.47%-1.35-26.74%-1.09-19.81%-1.27-64.29%-1.6139.19%-4.056.61%-1.13
Diluted earnings per share -5.50%-1.1519.69%-1.0250.93%-0.79-31.11%-5.31-19.47%-1.35-26.74%-1.09-19.81%-1.27-64.29%-1.6139.19%-4.056.61%-1.13
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data